NSE:KIMS's Gross Margin % is ranked better than 79.52% of 630
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs NSE:KIMS: 70.81
Krishna Institute of Medical Sciences had a gross margin of 61.60% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Krishna Institute of Medical Sciences (NSE:KIMS) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Krishna Institute of Medical Sciences had a gross margin of 61.60% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Krishna Institute of Medical Sciences Gross Margin % Related Terms
Krishna Institute of Medical Sciences Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krishna Institute of Medical Sciences Gross Margin % Chart
NSE:KIMS vs HCA, THC, DVA: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Krishna Institute of Medical Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krishna Institute of Medical Sciences Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Krishna Institute of Medical Sciences's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Krishna Institute of Medical Sciences's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Krishna Institute of Medical Sciences (NSE:KIMS) has a Gross Margin % of 61.60% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Krishna Institute of Medical Sciences and its competitors. This is near median its historical median of 61.83. Over the past decade, Krishna Institute of Medical Sciences' Gross Margin % has ranged from 59.34 to 70.81. According to the industry distribution chart, Krishna Institute of Medical Sciences ranks #129 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 20.5%.
Is Krishna Institute of Medical Sciences' Gross Margin % too high?
Krishna Institute of Medical Sciences' current Gross Margin % of 61.60% is near median its 10-year median of 61.83. Over the past 10 years, this metric has ranged from a low of 59.34 to a high of 70.81. The Healthcare Providers & Services industry median Gross Margin % is 40.08. Krishna Institute of Medical Sciences' value of 61.60% is 53.7% above this industry median. Based on the distribution chart, Krishna Institute of Medical Sciences ranks #129 out of 630 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' Gross Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Krishna Institute of Medical Sciences ranks #129 out of 630 companies for Gross Margin %. This places Krishna Institute of Medical Sciences in the top 21% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.08. Krishna Institute of Medical Sciences' value of 61.60% is 53.7% above this benchmark. Historically, Krishna Institute of Medical Sciences' own Gross Margin % has ranged from 59.34 to 70.81 over the past decade. While the company's 10-year median is 61.83 vs. the industry median of 40.08, Krishna Institute of Medical Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krishna Institute of Medical Sciences's current Gross Margin % of 61.60% is 53.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Krishna Institute of Medical Sciences and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krishna Institute of Medical Sciences's current Gross Margin % is 61.60%, which is near median its own 10-year median of 61.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹779.51, compared to a current price of ₹850.65 — trading 9.1% above its estimated fair value. The current Gross Margin % is 61.60%, which is near median its 10-year median of 61.83 and 53.7% above the Healthcare Providers & Services industry median of 40.08. Krishna Institute of Medical Sciences' overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current Gross Margin % is 61.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be overvalued.
The current stock price of ₹850.65 is trading 9.1% above its estimated GF Value™ of ₹779.51.
GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.
Key valuation signals for NSE:KIMS:
Gross Margin %: 61.60% (near median its 10-year median of 61.83)
GF Value™: ₹779.51 vs. price of ₹850.65 (9.1% above fair value)
Industry Position: 53.7% above the Healthcare Providers & Services median (#129 of 630)
No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krishna Institute of Medical Sciences Business Description
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
86GF Score
Get the complete analysis for NSE:KIMS
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KIMS has been successfully added to your 
